Physician profile
Laura Boucher
NPI 1770085243
$802.18
in general payments reported to CMS, 2019-2025
18 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $51.69 · 2023: $261 · 2024: $344 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $214.66 | 2023 | Excelsiusgps Robotic Navigation System |
| Averitas Pharma INC. | $94.90 | 2023-2025 | Qutenza |
| Medtronic, INC. | $89.17 | 2024-2025 | Metrx System, Unid_pass, Intellis Adaptivestim |
| Nico Corporation | $67.05 | 2024 | |
| Depuy Synthes Sales INC. | $40.13 | 2025 | |
| Saluda Medical Americas, INC. | $35.50 | 2024 | Evoke |
| Collegium Pharmaceutical, INC. | $29.05 | 2024 | Belbuca |
| Nevro Corp. | $28.98 | 2024 | Senza |
| Janssen Pharmaceuticals, INC | $26.40 | 2023 | Xarelto |
| Spr Therapeutics, INC | $25.67 | 2024 | Sprint Pns System |
| Baxter Healthcare | $23.16 | 2025 | Floseal |
| Pacira Pharmaceuticals Incorporated | $22.89 | 2024 | Iovera, Zilretta |
| Abbvie INC. | $20.29 | 2022 | |
| Stryker Corporation | $20.11 | 2025 | Universal Neuro 3 |
| Boston Scientific Corporation | $18.06 | 2024 | Wavewriter Alpha Prime 16 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $17.78 | 2022 | |
| Chiesi USA, INC. | $14.76 | 2025 | Cleviprex |
| Ferring Pharmaceuticals INC. | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Boucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.